This report provides exclusive insights into the COVID-19 impact on the Preclinical Imaging Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Preclinical Imaging Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Preclinical Imaging Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on
preclinical imaging market provides an in-depth analysis of segments and
sub-segments in the global as well as regional preclinical imaging market. The
study also highlights the impact of drivers, restraints, and macro indicators
on the global and regional preclinical imaging market over the short term as
well as long term. The report is a comprehensive presentation of trends,
forecast and dollar values of global preclinical imaging market. According to
the report, the global preclinical imaging market is projected to grow at a
CAGR of 5.3% over the forecast period of 2019-2025.
Preclinical imaging is used in live animal for drug development.
Further, it is used to monitor the treatment response of efficacy. This imaging
continues to provide crucial data sets to scientists in cardiology, neurology
and metabolic disease. A small animal imaging provides a piece of spatially,
quantitative and temporally-indexed information on diseased and normal tissues
such as tumors. This allows monitoring of diseases progression as well as
treatment options over a period of time. The most used imaging modalities are
positron emission tomography (PET), optical (bioluminescence and fluorescence),
magnetic resonance imaging (MRI). The multiple imaging modalities are provided
information on molecular features, metabolism, and function all within the
context of anatomical structure and localization.
The growth in the prevalence of chronic diseases such as cancer,
cardiovascular, rheumatoid arthritis, and neurological disorders are driving
the global preclinical imaging market. Further, government funding for research
and development activities, technological advancements in the field of
molecular imaging and growing demand for non-invasive imaging techniques
provides a demand for the market. However, high operation and installation cost
associated with preclinical imaging are hindering the growth of the market.
Moreover, growing research infrastructure provides growth opportunities for
preclinical imaging market.
North America is anticipated to dominate the preclinical imaging
market owing to growth in the prevalence of chronic diseases such as cancer,
rapid adoption of several types of modalities by the end-user, cardiovascular
disease, and technological advancement. Europe is the second-largest region for
the preclinical imaging market owing to the increasing number of research and
development activities and growing health care awareness among people. The
Asia-Pacific is expected to grow with healthy CAGR owing to government support
for research and development activities, growing population and opportunity for
clinical and preclinical studies at low cost.
The report on global preclinical imaging market covers segments
such as product, application, and end-user. On the basis of product, the
sub-markets include modalities, and reagents. On the basis of application, the
sub-markets include research and development, and drug discovery. On the basis
of end-user, the sub-markets include pharmaceutical companies, biotech
companies, and research institutes.
The report provides profiles of the companies in the market such
as MR Solutions, TriFoil Imaging, Bruker Corporation, PerkinElmer Inc, FUJIFILM
Holdings America Corporation, Mediso Ltd, Miltenyi Biotec, Aspect Imaging,
Li-Cor Biosciences, and MILabs B.V.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of preclinical
imaging market. Moreover, the study highlights current market trends and
provides forecast from 2019-2025. We also have highlighted future trends in the
market that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.